Week 419 Review - Almost everything drops and I buy a load of SkinBioTherapeutics

A red week all round, with the miners particularly hard hit. OPTI:Optibiotix didn't move, but all the other losses dragged the portfolio down by £1,039 and left the deficit between cost and value at £80,328. Portfolio value increased to £111,654 as I injected another £5,000.

Worst performer was ANTO:Antofagasta, and to make matters worse the slide came after a spike upwards which is when I bought my monthly shares, so my average price increased just before it dropped 8%.

CEY:Centamin and EDV:Endeavour Mining didn't do much better, both dropping 7% as the gold price wavered.

PSN:Persimmon also dropped 7% as the house builders took a hit.

JLP:Jubilee Metals has been drifting really badly and fell between 4% and 6% in my various holdings.

CAML:Central Asia Metals also dropped 5% as the miners slumped.

GAW:Games Workshop had a bad week, dropping 5% but is still 12% in profit.

Share of the Week is SBTX:SkinBioTherapeutics, which climbed between 9% and 11% in my existing holdings, and is 3% in profit for the new shares I bought this week.

Here's the ISA and shares portfolio after week 3 of year 9.

			Weekly Change
Cash	£152.28		-£1.52
Portfolio cost	£93,364.33		+£4,999.91
Portfolio sell value (bid price-commission)	£52,800.88	(-43.4%)	-£356.07
Potential profits	£3,030.73		+£118.55
Yr 9 Dividends	£0		+£0
Yr 9 Interest	£0.47		+£0.47
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	-£7.74	(-0.1%)	+£0.39
Total Dividends	£11,911.43		+£0
Total Interest	£2.40		+£0.47
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£298.14	(5.5%)	-£0.73
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	44%		-4%

Value only dropped by £356, which isn't bad given what a dreadful week it was for most of the portfolio. Potential profits rose by £118 but that's all thanks to a timely purchase.

I've been decidedly miffed at the performance of my premium bonds for the last 2 months, generating £25 from 50,000. Although the whole point of keeping them is to have access to cash if I need it, I figured I could get by with 45,000. I've been increasingly optimistic about the potential of SBTX:SkinBioTherapeutics recently, and my holding was only 8,036 shares, so I wanted a significant increase while they are still below 30p. I bought 22,527 at 22.151p costing £4,999.91 and they finished the week at 23p which is a potential profit of £171. I think 30p is achievable quite quickly which would put them up by £1,748, and if they get back to their recent peak of 80p I'll have £13,011 profit from the new shares and about £4,000 from the old ones. I think that will happen next year if Croda finally announce a deal.

The increase in portfolio cost dropped my long term performance from 6% to 5.5% and compound performance dropped by 4%, as it's measured against cash injection.

Always difficult to work out what's going on when there's a cash injection

That shows more accurately that it was an almost flat week, and the trend line is almost flat too.

The SIPP looks like this after week 403 overall and week 39 of year 8.

			Weekly Change
Cash	£151.15		-£1.16
Portfolio cost	£96,247.60		+£0
Portfolio sell value (bid price - commission)	£57,203.80	(-40.6%)	-£638.90
Potential profits	£4,204.94		-£45.73
Yr 8 Dividends	£239.37		+£0
Yr 8 Interest	£3.98		+£0.16
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£1,051.25	(-19.3%)	+£27.54
Total Dividends	£14,382.15		+£0
Total Interest	£4.23		+£0.16
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£259.34	(4.8%)	-£0.66
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

Cash dropped due to AJ Bell fees minus interest payments. This portfolio fared worse than the ISA due to having more exposure to miners, and III:3i Group dropped so potential profits are down £45. Otherwise rather quiet.

Not quite as flat as the ISA, but pretty flat.

This trend line is almost flat too.

The trading account looks like this after week 369 overall and week 5 of year 8.

			Weekly Change
Cash	£273.24		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£1,073.64	(-40.2%)	-£44.12
Potential profits	£0		+£0
Year 8 Dividends	£0		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£246.12	(+164.6%)	-£61.53
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.89	(-4.6%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

Everything fell in value, so we're back to the normal behaviour of this account. My BARC:Barclays purchase was another of my ill-timed disasters as they are down 13% now, although I will get a dividend next month.

Depressing

Gutted that we've dropped below the trend line. How can I be so bad at this?

A pretty flat week really, despite most shares having a bad week. The holdings are so small that it doesn't have the impact of a move in OPTI:Optibiotix or PBX:Probiotix, but it shows that I can still lose £1,000 if almost everything drops a little.

I've given up on getting any OPTI:Optibiotix news until September now. Everyone is on holiday, so there's no chance of getting any contracts signed. The fact the share price stayed flat was a massive relief as I thought it would continue to drift back down. Let's hope it doesn't do that for the next 2 weeks until we get into September.